D. E. Shaw & Co. Inc. Buys 880,573 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

D. E. Shaw & Co. Inc. boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 97.3% during the 1st quarter, HoldingsChannel reports. The fund owned 1,785,698 shares of the real estate investment trust’s stock after acquiring an additional 880,573 shares during the quarter. D. E. Shaw & Co. Inc.’s holdings in Omega Healthcare Investors were worth $65,410,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of OHI. Stonebridge Capital Advisors LLC acquired a new stake in Omega Healthcare Investors in the 1st quarter valued at $26,000. Edmond DE Rothschild Holding S.A. acquired a new stake in Omega Healthcare Investors in the 1st quarter valued at $29,000. Cullen Frost Bankers Inc. acquired a new stake in Omega Healthcare Investors in the 1st quarter valued at $30,000. Capital Analysts LLC acquired a new stake in Omega Healthcare Investors in the 1st quarter valued at $32,000. Finally, Arkadios Wealth Advisors increased its stake in Omega Healthcare Investors by 63.6% in the 1st quarter. Arkadios Wealth Advisors now owns 983 shares of the real estate investment trust’s stock valued at $36,000 after buying an additional 382 shares during the last quarter. 69.23% of the stock is currently owned by institutional investors and hedge funds.

Shares of OHI opened at $37.46 on Thursday. Omega Healthcare Investors, Inc. has a 52 week low of $28.08 and a 52 week high of $39.31. The firm has a market cap of $8.82 billion, a price-to-earnings ratio of 37.82, a P/E/G ratio of 4.79 and a beta of 1.00. The firm has a 50-day moving average of $36.78. The company has a debt-to-equity ratio of 1.30, a quick ratio of 3.73 and a current ratio of 3.73.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Sunday, May 2nd. The real estate investment trust reported $0.69 EPS for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.24. Omega Healthcare Investors had a net margin of 25.12% and a return on equity of 5.63%. The business had revenue of $234.83 million for the quarter, compared to analyst estimates of $225.64 million. During the same quarter in the prior year, the business earned $0.79 EPS. Omega Healthcare Investors’s quarterly revenue was up 7.7% on a year-over-year basis. Analysts anticipate that Omega Healthcare Investors, Inc. will post 3.22 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, May 17th. Investors of record on Monday, May 3rd were paid a $0.67 dividend. The ex-dividend date of this dividend was Friday, April 30th. This represents a $2.68 dividend on an annualized basis and a yield of 7.15%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 82.97%.

Several equities research analysts have issued reports on the stock. TheStreet upgraded shares of Omega Healthcare Investors from a “c+” rating to a “b-” rating in a research note on Monday, April 5th. Wolfe Research started coverage on shares of Omega Healthcare Investors in a research note on Monday, June 14th. They set a “peer perform” rating and a $43.00 price objective on the stock. Mizuho restated a “neutral” rating and set a $39.00 price objective on shares of Omega Healthcare Investors in a research note on Wednesday, July 14th. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, July 14th. Finally, JMP Securities restated an “outperform” rating and set a $43.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, May 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $38.62.

In other Omega Healthcare Investors news, insider Steven J. Insoft sold 25,000 shares of the business’s stock in a transaction dated Monday, June 21st. The shares were sold at an average price of $36.69, for a total value of $917,250.00. Following the completion of the sale, the insider now owns 184,588 shares of the company’s stock, valued at approximately $6,772,533.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders purchased 1,255 shares of company stock worth $45,884. 1.16% of the stock is owned by company insiders.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Read More: How does equity income fit into an investing strategy?

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.